- Laboratory
- Laboratory medicine
- Rapid respiratory disease test
- BIOMED-Labordiagnostik GmbH
- Products
- Catalogs
- News & Trends
- Exhibitions
Rapid respiratory disease test for antigensSARS-COV-2coronavirus
Add to favorites
Compare this product
Characteristics
- Applications
- for respiratory diseases
- Tested parameter
- for antigens
- Micro-organism
- SARS-COV-2, coronavirus
- Sample type
- nasopharyngeal
- Analysis mode
- immunoassay, lateral flow
- Specificity
99.7 %
- Sensitivity
93.8 %
Description
The 2019-nCoV Antigen Rapid Test is a lateral flow immunoassay based on latex immunochromatography technology and utilizes the double antibody sandwich method for the qualitative detection of Coronavirus SARS-CoV-2 antigen in human nasopharyngeal and oropharyngeal swab specimens. Reliably tests all known variants including delta, omicron, lambda, etc.
This test principle of the 2019-nCoV antigen rapid tests is characterized by a high specificity (99.7%) and sensitivity (93.8%). The application is carried out by appropriately trained personnel.
Other BIOMED-Labordiagnostik GmbH products
POC-Diagnostic
Related Searches
- Reagent kit
- Solution reagent kit
- Molecular biology reagent kit
- Liquid reagent kit
- Laboratory reagent kit
- Diagnostic reagent kit
- Rapid lateral flow test
- Protein reagent kit
- Immunoassay rapid diagnostic test
- Virus rapid diagnostic test
- Reagent medium reagent kit
- Clinical chemistry reagent
- Cytology reagent kit
- Infectious disease rapid diagnostic test
- Rapid respiratory infection test
- Quality control reagent kit
- Bacteria reagent kit
- Clinical reagent kit
- Microbiology reagent kit
- Serum reagent kit
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.